Log in to save to my catalogue

Impact of HOXB4 and PRDM16 Gene Expressions on Prognosis and Treatment Response in Acute Myeloid Leu...

Impact of HOXB4 and PRDM16 Gene Expressions on Prognosis and Treatment Response in Acute Myeloid Leu...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_22060302afd34f1cabdea2b74d888449

Impact of HOXB4 and PRDM16 Gene Expressions on Prognosis and Treatment Response in Acute Myeloid Leukemia Patients

About this item

Full title

Impact of HOXB4 and PRDM16 Gene Expressions on Prognosis and Treatment Response in Acute Myeloid Leukemia Patients

Publisher

Macclesfield: Dove Medical Press Limited

Journal title

Pharmacogenomics and personalized medicine, 2022-06, Vol.15, p.663-674

Language

English

Formats

Publication information

Publisher

Macclesfield: Dove Medical Press Limited

More information

Scope and Contents

Contents

Introduction: Acute myeloid leukemia (AML) is the most common type of leukemia among adults and is characterized by various genetic abnormalities. HOXB4 and PRDM16 are promising markers of AML. Our objective is to assess the potential roles of HOXB4 and PRDM16 as prognostic and predictive markers in newly diagnosed AML patients and determine the co...

Alternative Titles

Full title

Impact of HOXB4 and PRDM16 Gene Expressions on Prognosis and Treatment Response in Acute Myeloid Leukemia Patients

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_22060302afd34f1cabdea2b74d888449

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_22060302afd34f1cabdea2b74d888449

Other Identifiers

ISSN

1178-7066

E-ISSN

1178-7066

DOI

10.2147/PGPM.S368640

How to access this item